기본 정보
- CAS
40762-15-0- 표준 SMILES
O=C1C(O)N=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO- InChIKey
VOJLELRQLPENHL-UHFFFAOYSA-N- 분자식
- C17H14ClFN2O3
- 평균 분자량
- 348.8 g/mol
- 단동위원소 질량
- 348.0676982
개요
Doxefazepam is a benzodiazepine.
이름 및 식별자
- 우선 이름
- Doxefazepam
- IUPAC
- 7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one
- 영어명
- Doxefazepam
- 분자식
- C17H14ClFN2O3
- 분자량
- 348.76
이름 및 동의어
Doxefazepam40762-15-0DoxefazepamumSAS-643N-1-Hydroxyethyl-3-hydroxyflurazepam231RV72C8LDTXSID20205511-(2-hydroxyethyl)-3-hydroxy-7-chloro-1,3-dihydro-5-(o-fluorophenyl)-2H-1,4-benzodiazepin-2-oneRefChem:135726DTXCID80551N05CD127-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
이름 더 보기
doxefaxepamDUFLURAZEPAMDoxefazepam USP/EP/BP7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-1-(2-hydroxyethyl)-2H-1,4-benzodiazepin-2-one1,3-Dihydro-7-chloro-5-(o-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-2H-1,4-benzodiazepin-2-one2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-1-(2-hydroxyethyl)-
DoxansDoxefazepam [INN]7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-oneDoxefazepam (INN)7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-3-hydroxy-1-(2-hydroxyethyl)-2H-1,4-benzodiazepin-2-oneDoxefazepamum [INN-Latin]Sas 643
데이터베이스 식별자
- CAS
40762-15-0- PubChem CID
- 38668
- DTXSID
DTXSID2020551- ChEMBL
CHEMBL64677- ChEBI
CHEBI:82460- UNII
- 231RV72C8L
- Nikkaji
- J16.569G
물성
구조 계산 물성
- XLogP
- 1.6
- 극성 표면적
- 73.1 Ų
- 수소 결합 공여자 수
- 2
- 수소 결합 수용자 수
- 5
- 회전 가능 결합 수
- 3
- 무거운 원자 수
- 24
- 형식 전하
- 0
- 복잡도
- 504
실험 및 물리화학적 성질
Drugs
Pharmaceuticals -> Nervous system -> Anxiolytics
Pharmaceuticals -> Benzodiazepines
LogP1.52
물리화학적 성질
- 녹는점
- 138 · 138-140°
- 끓는 점
- 204.52 °C · 204.52°C (rough estimate)
- 밀도
- 1.3534 · 1.3534 (estimate)
- 저장 조건
- -20 °C · Store at -20°C
- 산도 계수 (pKa)
- 11.55 · 11.55±0.40(Predicted)
- 물리적 상태
- Solid
- 색상
- White to off-white
- InChI
- InChI=1S/C17H14ClFN2O3/c18-10-5-6-14-12(9-10)15(11-3-1-2-4-13(11)19)20-16(23)17(24)21(14)7-8-22/h1-6,9,16,22-23H,7-8H2
- InChIKey
- VOJLELRQLPENHL-UHFFFAOYSA-N
- SMILES
- N1(CCO)C2=CC=C(Cl)C=C2C(C2=CC=CC=C2F)=NC(O)C1=O
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
독성 정보
Treatment
General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.
Toxicity Summary
Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
Carcinogen Classification
Doxefazepam
Group 3: Not classifiable as to its carcinogenicity to humans
Volume 66: (1996) Some Pharmaceutical Drugs
1996
1996
3, not classifiable as to its carcinogenicity to humans. (L135)
안전 데이터
- ridadr
- 3249
- 독성
- LD50 in rats, mice (mg/kg): 2550, >1500 orally; 586, 774 i.p. (Babbini)
- 포장분류
- III
- 위험 등급
- 6.1(b)
화학 및 산업
약리 정보
ATC Code
N - Nervous system
QN - Nervous system
용도 및 제조
UsesDoxefazepam is used therapeutically as a hypnotic.
응용 분야
개요Doxefazepam is a benzodiazepine hypnotic somewhat more potent than flurazepam.
공급사5 곳
宝鸡缔都医药化工有限公司029-81145305 17791533577 · [email protected]
成都凯泰创医药科技有限公司16608035117 · [email protected]
上海超岚化工科技中心QQ：65489617 13301690235 · [email protected]
BOC Sciences+1-631-485-4226 · [email protected]
广州优南科技有限公司020-82000279 18988941452 · [email protected]
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…